The functioning of the hypothalamo-pituitary-adrenal axis was assessed in 10 adult women with idiopathic hirsutism treated for 2 weeks with the anti-androgen cyproterone acetate in a dose of 50 mg b. d. daily and in 4 patients treated for at least 3 months.
varying from 1 mg to 50 mg/kg body weight (Winkler & Harkness 1964; Domenico 8c Neumann 1967; Neri et al. 1967; Denef et al. 1968; Schreiber et al. 1971; Broulik 8c Starka 1975; Zieger et al. 1976; Purvis et al. 1976; Girard 8c Baumann 1975) . This effect has been ascribed to a corticosteroid like action of cyproterone acetate (Broulik 8c Starka 1975) . Very recently also evi¬ dence for adrenal insufficiency has been found in children treated with cypro¬ terone acetate because of precocious puberty (Girard 8c Baumann 1975; Fried et al. 1976; Jeffcoate et al. 1976; Zurbrügg 1976; von Mühlendahl et al. 1977 ).
To [-'H] cortisol were added and after incubation at 4°C for 18 h bound and free hormone were separated by Dextran-coated charcoal. Replicate analysis of a plasma pool with a cortisol level of 6 jtg/100 ml disclosed intra-and inter-assay coefficients of variation of 5 and 10%>, respectively. The inter-assay duplicate varia¬ tion determined from determination of samples containing 3.5 to 7, 7 to 10 and 10 to 20 «g/100 ml were 8.6, 7.4 and 4.3%, respectively (n=17 (Fig. 2) The hypoglycaemia responses to insulin before and during cyproterone acetate treatment were about equal with lowest blood glucose levels of 31.1 + 7.0 and 31.2 ± 4.0 mg/100 ml, respectively (P > 0.1) 20 min after the insulin injection.
The mean basal plasma ACTH levels were 14.2 ± 8.0 before and 9.1 ± 3.1 pg/ml during cyproterone acetate therapy (P > 0.10). induced hypoglycaemia the mean plasma ACTH levels rose to 156 ± 162 pg/ml before and to 138 ± 66 pg/ml during treatment (P>0.10). In 4 patients the maximal ACTH increment was higher during than before treatment, in 3 pa¬ tients lower.
The mean basal plasma cortisol levels at time 0, respectively, were 10.5 ± 3.6 before and 12.9 ± 3.6 pig/100 ml (P > 0.10) during treatment. After a statisti¬ cally significant initial fall to 9.4 ± 2.8 and 9.8 ± 1.8 pig/100 ml at 20 min after insulin injection, plasma cortisol levels at 60 min maximally rose to 18.4 ± 5.7 jig/100 ml before and 23.1 ± 5.1 pig/100 ml during treatment (P>0.10). The hypoglycaemia preceded the ACTH peak by 12.8 ± 5.7 min before and by 17.1 ± 7.5 min during cyproterone acetate therapy (P1' > 0.10), whereas the corresponding time intervals between the ACTH and plasma cor¬ tisol peaks were 20 ± 20 min before and 25 ± 19 min during the anti-androgen treatment (P;:>0.10).
insulin'0.1 U/kg 3. Effect of 3 months antiandrogen therapy
The mean plasma cortisol levels in the 4 patients treated with cyproterone acetate for at least 3 months were 12.3 ± 3.5 /ig/100 ml before and 13.7 ± 1.8, 13.3 ± 5.1 and 13 ± 1.2 pig/100 ml (respectively after V2, 2 and 3 months of treatment) (P > 0.10). Very recently adrenal insufficiency also has been reported in children with precocious puberty, treated with cyproterone acetate in doses varying from 60 to 210 mg/m2/day for 0.1 to 5.8 years (Girard 8c Baumann 1975; Fried et al. 1976; Zurbrügg 1976; Jeffcoate et al. 1976; von Mühlendahl et al. 1977) . Basal plasma cortisol levels after therapy were low and showed a blunted response to ACTH stimulation (Fried et al. 1976; Jeffcoate et al. 1976 ). In contrast with these reports Angeli et al. (1976) 
